Cargando…
Treat to Target (Drug-Free) Inactive Disease in JIA: To What Extent Is This Possible?
Background: Treat to target (T2T) is a strategy that has been increasingly employed in the management of several chronic diseases, with demonstrated improved outcomes. The use of T2T in juvenile idiopathic arthritis (JIA), a common rheumatic disease of childhood, is still in its infancy, and the fea...
Autores principales: | Ramanan, Athimalaipet V., Sage, Anne M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9570877/ https://www.ncbi.nlm.nih.gov/pubmed/36233546 http://dx.doi.org/10.3390/jcm11195674 |
Ejemplares similares
-
The risk of uveitis in patients with JIA receiving etanercept: the challenges of analysing real-world data
por: Davies, Rebecca, et al.
Publicado: (2020) -
Polyarticular juvenile idiopathic arthritis (pJIA): clinical and serologic predictors of inactive disease (ID)
por: Meiorin, Silvia
Publicado: (2014) -
A phase II trial protocol of Tocilizumab in anti-TNF refractory patients with JIA-associated uveitis (the APTITUDE trial)
por: Ramanan, Athimalaipet V., et al.
Publicado: (2018) -
Coronavirus Disease 2019 (COVID-19) in Children - What We Know So Far and What We Do Not
por: Balasubramanian, S., et al.
Publicado: (2020) -
Inactive disease and remission rates after intraarticular steroids as initial therapy for juvenile idiopathic arhtritis (JIA)
por: Sato, JO, et al.
Publicado: (2011)